Narrative review highlights limited data on connective tissue disease-associated PAH in Han Chinese populations

This narrative review addresses the scarcity of contemporary data regarding connective tissue disease-associated pulmonary arterial hypertension within Han Chinese populations. The scope includes systemic sclerosis-associated PAH and systemic lupus erythematosus-associated PAH, acknowledging that specific details on interventions, comparators, and outcomes were not reported in the source text. The review highlights that current evidence is insufficient to fully characterize clinical characteristics and prognosis for this specific demographic.

The authors emphasize that existing literature lacks comprehensive data on these conditions in Han Chinese groups. This gap limits the ability to draw definitive conclusions about disease progression or treatment efficacy in this population. The review serves to identify these critical knowledge gaps rather than providing pooled effect sizes or specific adverse event rates.

The primary limitation identified is the overall scarcity of contemporary data on clinical characteristics and prognosis in Han Chinese populations. The authors conclude that targeted studies are required to optimize diagnostic and therapeutic strategies. Such research is essential to improve patient outcomes and address the current lack of specific evidence for this demographic.